Download App

Log in to access Online Inquiry
Company Overview More
Tengsheng Boyao Biotechnology Co., Ltd. is a biotechnology company headquartered in China and the United States, mainly engaged in infectious disease therapy research and development business. The company's products are used in infectious diseases (such as hepatitis B virus (HBV), human immunodeficiency virus (HIV), multidrug-resistant (MDR) or extensively drug-resistant (XDR) Gram-negative bacteria infections) and other diseases with significant public health burdens, such as central nervous system (CNS) diseases. The company also develops treatments for COVID-19 and others.
CEO: Zhi HONG
Market: Hong Kong motherboard
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

Moomoo > Quotes > 02137 BRII-B > Detailed Quotes

02137 BRII-B

8.710+0.040+0.46%
Closed 05/20 16:08 CCT
High
8.890
Open
8.890
Turnover
53.31M
Low
8.530
Pre Close
8.670
Volume
6.09M
Market Cap
6.29B
P/E(TTM)
Loss
52wk High
52.600
Shares
722.30M
P/E(Static)
Loss
52wk Low
7.150
Float Cap
6.29B
Bid/Ask %
66.67%
Historical High
52.600
Shs Float
722.30M
Volume Ratio
0.77
Historical Low
7.150
Dividend TTM
--
Div Yield TTM
--
P/B
1.54
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
0.84%
Amplitude
4.15%
Avg Price
8.746
Lot Size
500
Float Cap
6.29B
Bid/Ask %
66.67%
Historical High
52.600
Shs Float
722.30M
Volume Ratio
0.77
Historical Low
7.150
Dividend TTM
--
P/B
1.54
Dividend LFY
--
Turnover Ratio
0.84%
Amplitude
4.15%
Avg Price
8.746
Lot Size
500
Price Forecast

No Data

News

Comment

No More